The Female Health Company (AMEX: FHC), the sole manufacturer and marketer of the FC1 and FC2 female condoms, provides an innovative option to women that protects against both sexually transmitted diseases and unintended pregnancy. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People’s Republic of China, South Korea and Japan, while patents are pending for FC2. For further information, visit the Company’s web site at www.femalehealth.com.
- 17 years ago
QualityStocks
The Female Health Company (AMEX: FHC)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for primary and metastatic cancers of the…
-
Forward Industries Inc. (NASDAQ: FWDI) Gains Buy Rating as Solana-Focused Treasury Strategy Strengthens Outlook
Earlier this year, Forward Industries pivoted toward digital asset management, transforming into the world’s largest…
-
Oncotelic Therapeutics Inc. (OTLC) Leverages Nanoparticles to Re-Imagine Drug Delivery in Oncology
Research indicates that the advantages of nanoparticle delivery in pharma are significant Oncotelic Therapeutics has…